|
1. Maximizing safe resection of low- and high-grade glioma(大限度順利地切除低級別和高級別膠質(zhì)瘤)
2. Seizure Outcome After Surgical Resection of Insular Glioma(島葉膠質(zhì)瘤手術(shù)切除后的癲癇預(yù)后)
3. Prioritization schema for immunotherapy clinical trials in glioblastoma(膠質(zhì)母細(xì)胞瘤免疫治療臨床試驗的優(yōu)先方案)
4. Magnetic resonance analysis of malignant transformation in recurrent glioma(復(fù)發(fā)性膠質(zhì)瘤惡變的磁共振分析)
5. Insular glioma resection: assessment of patient morbidity, survival, and tumor progression(島葉膠質(zhì)瘤切除術(shù)：患者發(fā)病率，存活率和腫瘤進(jìn)展的評估)
6. Perioperative outcomes following reoperation for recurrent insular gliomas(復(fù)發(fā)性島葉膠質(zhì)瘤再次手術(shù)后的圍手術(shù)期結(jié)局)
7. Surgical outcomes in spinal cord ependymomas and the importance of extent of resection in children and young adults(脊髓室管膜瘤的手術(shù)結(jié)果以及切除范圍對兒童和青年患者的重要性)
8. Tuberculum sellae meningiomas: grading scale to assess surgical outcomes using the transcranial versus transsphenoidal approach(鞍結(jié)節(jié)腦膜瘤：使用經(jīng)顱與經(jīng)蝶竇方法評估手術(shù)結(jié)果的分級量表)
9. Future directions in treatment of brain metastases(腦轉(zhuǎn)移瘤治療的未來方向)
10. Low-grade gliomas(低級別膠質(zhì)瘤)
11. Glioma surgery: a century of challenge(膠質(zhì)瘤手術(shù)：一個世紀(jì)的挑戰(zhàn))
12. 5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas(5-氨基乙酰丙酸熒光引導(dǎo)手術(shù)治療復(fù)發(fā)性高級別膠質(zhì)瘤)
13. Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma(替莫唑胺治療復(fù)發(fā)性高級別膠質(zhì)瘤7天/ 7天的II期試驗)
14. Current perspectives on neuro-oncology(神經(jīng)腫瘤學(xué)研究現(xiàn)狀)
15. Evolution of management strategies for cerebral gliomas: the effects of science and technology(腦膠質(zhì)瘤治療策略的演變：科學(xué)和技術(shù)的影響)
16. Translational research strategies applied to glioma therapeutics(適用于膠質(zhì)瘤治療的轉(zhuǎn)化研究策略)
17. Low-grade gliomas in adults(成人低級別膠質(zhì)瘤)
18. Disseminated progression of glioblastoma after treatment with bevacizumab(用貝伐單抗治療彌散性膠質(zhì)母細(xì)胞瘤的進(jìn)展)
19. Brain metastases of breast cancer(乳腺癌的腦轉(zhuǎn)移)
20. Neurosurgical management and prognosis of patients with glioblastoma that progresses during bevacizumab treatment(貝伐單抗治療進(jìn)展期膠質(zhì)母細(xì)胞瘤患者的神經(jīng)外科治療和預(yù)后)
21. The superiority of conservative resection and adjuvant radiation for craniopharyngiomas(顱咽管瘤保守切除和輔助放射治療的優(yōu)越性)
22. Current and future strategies for treatment of glioma(膠質(zhì)瘤治療的現(xiàn)在與未來展望)
23. Surgical technique of temporary arterial occlusion in the operative management of spinal hemangioblastomas(脊髓血管母細(xì)胞瘤手術(shù)治療中暫時性動脈閉塞的外科技術(shù))
24. Molecular features and clinical outcomes in surgically treated low-grade diffuse gliomas in patients over the age of 60(60歲以上患者低級別彌漫性膠質(zhì)瘤手術(shù)治療的分子特征和臨床結(jié)果)
25. Long-term seizure control outcomes after resection of gangliogliomas(神經(jīng)膠質(zhì)瘤切除術(shù)后長期癲癇發(fā)作的控制結(jié)果)
26. Intraoperative stimulation techniques for functional pathway preservation and glioma resection(術(shù)中刺激技術(shù)用于功能性通路保留和膠質(zhì)瘤切除術(shù))
27. Pediatric intracranial ependymoma: the roles of surgery, radiation and chemotherapy(小兒顱內(nèi)室管膜瘤：手術(shù)，放療和化療的作用)
28. Risk factors for the development of serious medical complications after resection of meningiomas. Clinical article(腦膜瘤切除術(shù)后發(fā)生嚴(yán)重并發(fā)癥的危險因素-臨床文章)
29. Preoperative prognostic classification system for hemispheric low-grade gliomas in adults(成人大腦半球低級別膠質(zhì)瘤的術(shù)前預(yù)后分類系統(tǒng))
30. Seizure characteristics and control following resection in 332 patients with low-grade gliomas(332例低級別膠質(zhì)瘤患者的癲癇發(fā)作特點(diǎn)及控制) |
